Market Overview

Biocom Appoints Two New Board Members and Adds to Its Executive Committee

Share:

Biocom, the association representing the California life science
industry, today announced the appointment of two new members to its
board of directors: Deanne Calvert, J.D., head of state government
relations for Sanofi US, and Ranjeet Banerjee, worldwide president of
Medication Management Solutions for BD, a leading global medical
technology company. Ms. Calvert will be replacing the board position of
Gregory Fond, director of strategy, science policy & external innovation
at Sanofi. In addition, Biocom announced that current board member
Steven Pacelli, executive vice president of strategy & corporate
development at Dexcom, will also join the executive committee.

"Ms. Calvert and Mr. Banerjee's specific and comprehensive skillsets in
government relations and medical device business operations and driving
new medical technology and informatics innovations to market,
respectively, are invaluable additions to Biocom's board of directors,
and Steve has made great contributions to our board already," said Joe
Panetta, president and CEO of Biocom. "They will bring diverse points of
view that will help inform Biocom's strategic growth as we serve our
more than 1,100 members across the state of California."

Deanne Calvert is head of state government relations for Sanofi US. Ms.
Calvert has worked in the state legislative environment for over twenty
years. Her career began as staff to the Washington Senate, before she
founded a Washington State legislative counsel practice in the Seattle
office of APCO Public Affairs, where she served as vice president. She
joined Sanofi in 2001 to lead its West Coast government affairs region.
In 2018, she was appointed to her current role as head of State
Government Relations in the United States. Deanne graduated with a
bachelor of arts in international relations magna cum laude from the
University of San Diego and a J.D. from University of Notre Dame Law
School (after attending the Concannon Program of International Law in
London, UK).

"With its culture of innovation and deep biotechnology history,
California is a national leader in the industry," said Ms. Calvert. "I
am grateful for the opportunity to work with Biocom to further its goals
and to enhance the opportunities for biotechnology initiatives in the
state."

Ranjeet Banerjee is the worldwide president of the Medication Management
Solutions (MMS) business unit for BD. Mr. Banerjee began his career with
BD in 1995 as a plant manager and was responsible for the start-up of
the BD India plant. In January 2001, he relocated to Singapore, serving
as the director of operations for BD Asia Pacific, and in July 2003 took
on the role of vice president of global operations for BD Medical –
Medical Surgical Systems. In October 2013, Mr. Banerjee assumed the role
of worldwide president of BD Medical – Diabetes Care. He moved into his
current role in January 2015 and is a member of the BD Medical segment
leadership team. He served on the leadership advisory council of the
Joint Commission's Center for Transforming Healthcare (2013-2014). Prior
to joining BD, Mr. Banerjee was with Unilever, India for nine years in
various management positions. He holds a bachelor of technology in
chemical engineering from the Indian Institute of Technology (IIT),
Kanpur, India. He serves on the board of directors for the California
Life Sciences Association and the San Diego Regional Economic
Development Corporation.

"It is a privilege to be named to Biocom's board of directors, and I
look forward to helping shape the association as it aims to accelerate
the development of cutting-edge innovations and drive public policy that
will help the life sciences economy grow in the San Diego region and
across California," said Mr. Banerjee. "It is an honor to be selected to
the board of an organization committed to driving medical technology
solutions that improve the human condition and is very much aligned with
our company purpose of advancing the world of health."

About Biocom

Biocom is the largest, most experienced leader and advocate for
California's life science sector. We work on behalf of more than 1,100
members to drive public
policy
, build an enviable network
of industry leaders
, create access
to capital
, introduce cutting-edge
STEM education programs
, and create robust value-driven purchasing
programs
.

Founded in 1995 in San Diego, Biocom provides the strongest public voice
to research institutions and companies that fuel the local and
state-wide economy. Our goal is simple: to help our members produce
novel solutions that improve the human condition. In addition to our San
Diego headquarters
, Biocom operates core offices in Los
Angeles
and the San
Francisco Bay Area
, satellite offices in Washington,
D.C.
 and Tokyo,
and has a continuous staff presence in Sacramento. Our broad membership
benefits apply to biotechnology, pharmaceutical, medical device,
genomics and diagnostics companies of all sizes, as well as to research
universities and institutes, clinical research organizations, investors
and service providers.

For more information on Biocom, please visit our website at www.biocom.org.
Connect with us on LinkedInFacebook,
and Twitter (@BIOCOMCA).

View Comments and Join the Discussion!